Mizuho Securities Reaffirms Their Sell Rating on Hims & Hers Health (HIMS)

Tip Ranks
2025.11.18 14:15
portai
I'm PortAI, I can summarize articles.

Mizuho Securities has reaffirmed its Sell rating on Hims & Hers Health (HIMS) with a price target of $30.00. Additionally, Bank of America Securities also issued a Sell rating, while Truist Financial maintained a Hold rating on the same day.

In a report released today, from Mizuho Securities maintained a Sell rating on Hims & Hers Health, with a price target of $30.00.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

In addition to Mizuho Securities, Hims & Hers Health also received a Sell from Bank of America Securities’s Allen Lutz in a report issued today. However, on the same day, Truist Financial maintained a Hold rating on Hims & Hers Health (NYSE: HIMS).

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.